Loomis Sayles & Co. L P trimmed its holdings in Itron, Inc. (NASDAQ:ITRI - Free Report) by 13.4% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 471,026 shares of the scientific and technical instruments company's stock after selling 72,859 shares during the quarter. Loomis Sayles & Co. L P owned about 1.04% of Itron worth $51,144,000 as of its most recent SEC filing.
Several other hedge funds also recently added to or reduced their stakes in the stock. Geode Capital Management LLC grew its stake in Itron by 0.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,074,940 shares of the scientific and technical instruments company's stock worth $114,835,000 after buying an additional 5,630 shares during the last quarter. Hennion & Walsh Asset Management Inc. boosted its holdings in shares of Itron by 78.3% in the fourth quarter. Hennion & Walsh Asset Management Inc. now owns 6,083 shares of the scientific and technical instruments company's stock valued at $660,000 after acquiring an additional 2,671 shares during the period. Intech Investment Management LLC grew its position in shares of Itron by 112.7% during the fourth quarter. Intech Investment Management LLC now owns 41,363 shares of the scientific and technical instruments company's stock worth $4,491,000 after acquiring an additional 21,919 shares during the last quarter. Systematic Financial Management LP increased its holdings in shares of Itron by 12.2% in the 3rd quarter. Systematic Financial Management LP now owns 134,362 shares of the scientific and technical instruments company's stock valued at $14,351,000 after acquiring an additional 14,590 shares during the period. Finally, Merit Financial Group LLC purchased a new stake in Itron in the 4th quarter valued at $301,000. 96.19% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Itron
In other Itron news, SVP Christopher E. Ware sold 648 shares of Itron stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $92.90, for a total transaction of $60,199.20. Following the transaction, the senior vice president now directly owns 20,326 shares of the company's stock, valued at $1,888,285.40. The trade was a 3.09 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Mary C. Hemmingsen sold 750 shares of the firm's stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $107.27, for a total value of $80,452.50. Following the completion of the transaction, the director now directly owns 5,630 shares in the company, valued at $603,930.10. This trade represents a 11.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 4,037 shares of company stock worth $385,815 in the last 90 days. 1.45% of the stock is owned by company insiders.
Itron Trading Up 0.5 %
Shares of NASDAQ:ITRI traded up $0.50 during midday trading on Tuesday, reaching $105.26. The company's stock had a trading volume of 59,285 shares, compared to its average volume of 553,339. The firm has a market cap of $4.80 billion, a price-to-earnings ratio of 21.56, a price-to-earnings-growth ratio of 0.81 and a beta of 1.49. The business has a 50 day moving average price of $104.20 and a 200 day moving average price of $108.05. Itron, Inc. has a 1 year low of $87.91 and a 1 year high of $124.90. The company has a quick ratio of 2.83, a current ratio of 3.36 and a debt-to-equity ratio of 0.91.
Analyst Ratings Changes
A number of research firms have commented on ITRI. Canaccord Genuity Group lifted their price objective on shares of Itron from $130.00 to $132.00 and gave the company a "buy" rating in a research note on Wednesday, February 26th. Guggenheim lowered their target price on Itron from $135.00 to $133.00 and set a "buy" rating on the stock in a research note on Thursday, February 27th. Oppenheimer lifted their price objective on shares of Itron from $124.00 to $131.00 and gave the company an "outperform" rating in a research report on Wednesday, February 26th. StockNews.com downgraded shares of Itron from a "strong-buy" rating to a "buy" rating in a research report on Saturday, March 1st. Finally, Piper Sandler boosted their target price on Itron from $119.00 to $124.00 and gave the stock a "neutral" rating in a research report on Thursday, February 27th. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $127.64.
View Our Latest Research Report on ITRI
Itron Profile
(
Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Featured Articles

Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.